blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2566859

EP2566859 - PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.10.2017
Database last updated on 26.04.2025
FormerThe patent has been granted
Status updated on  18.11.2016
FormerGrant of patent is intended
Status updated on  09.11.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Sk Chemicals Co., Ltd.
600 Jeongja-dong Jangan-gu Suwon-si
Gyeonggi-do 440-300 / KR
[2013/11]
Inventor(s)01 / RYU, Je Ho
101-506, KCC Apt.
1153 Sadang-dong
Dongjak-gu
Seoul 156-090 / KR
02 / KIM, Shin Ae
101, 572-3 bunji
Cheoncheon-dong
Jangan-gu
Suwon-si Gyeonggi-do 440-330 / KR
03 / RYU, Keun Ho
122-2001, Gwanak Dreamtown Apt.
Seonghyeon-dong
Gwanak-gu
Seoul 151-770 / KR
04 / KIM, Jae Sun
15/5, 1146-3
Seryu 2-dong
Gwonseon-gu
Suwon-si Gyeonggi-do 441-112 / KR
05 / KIM, Nam Ho
302-1403
Sinbongmaeul Xi 3 Cha Apt.
Sinbong-dong
Suji-gu
Yongin-si Gyeonggi-do 448-706 / KR
06 / HAN, Hye Young
104-1202, Ssangyong Apt.
Seongsu 1-ga 2 dong
Seongdong-gu
Seoul 133-756 / KR
07 / KIM, Yong Hyuk
301, 103-14
Yuljeon-dong
Jangan-gu
Suwon-si Gyeonggi-do 440-320 / KR
08 / YOUN, Won-No
1304 Cheongam Doosan Weve Apt.
Sillimbon-dong
Gwanak-gu
Seoul 151-711 / KR
09 / LEE, Yoon-Jung
601-203
Gahyeon Shinhan Apt.
334 Gugal-dong
Yongin-si Giheung-gu Gyeonggi-do 446-951 / KR
10 / SON, Hyun Joo
504 Jamwon Ivy
34-1, Jamwon-dong
Seocho-gu
Seoul 137-030 / KR
11 / LEE, Bong-yong
201-2103
Bangbae Raemiantower.
485-3, Bangbae-dong
Seocho-gu
Seoul 137-060 / KR
12 / PARK, Sung Hoon
201, 191-17
Eungbong-dong
Seongdong-gu
Seoul 133-080 / KR
13 / LEE, Ju Young
172-1604
Ggotmebeodeul Maeul Kolon Apt.
730bunji
Hwaseo-dong, Paldal-gu
Suwon-si Gyeonggi-do 442-150 / KR
14 / LEE, Hyun Jung
109-1102
Doosan Apt.
Hawolgok 4-dong
Seongbuk-gu
Seoul 136-130 / KR
15 / JUNG, Hoe Chul
1006-1209
Kkachi Maeul Apt.
Suseo-dong
Gangnam-gu
Seoul 135-520 / KR
16 / SHIN, Young Ah
113-103
Samsung Raemian 1-Cha Apt.
Mabuk-dong
Giheung-gu
Yongin- si Gyeonggi-do 446-557 / KR
17 / LEE, Jung A
Hanjin Rosehill Apt.
Ojeon-dong
Uiwang-si Gyeonggi-do 437-756 / KR
18 / LEE, Bo Ram
103-1801
Banpoxi Apt.
20-43, Banpo -dong
Seocho-gu
Seoul 137-040 / KR
19 / SA, Joon Ho
303, 222-15
Pungnap 1-dong
Songpa-gu
Seoul 138-041 / KR
 [2013/11]
Representative(s)Bassil, Nicholas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2016/51]Bassil, Nicholas Charles, et al
Kilburn & Strode LLP
20 Red Lion Street
London WC1R 4PJ / GB
Former [2013/11]Bassil, Nicholas Charles, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date11777588.204.05.2011
[2016/51]
WO2011KR03362
Priority number, dateKR2011003775822.04.2011         Original published format: KR 20110037758
KR2010004316807.05.2010         Original published format: KR 20100043168
[2013/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011139107
Date:10.11.2011
Language:EN
[2011/45]
Type: A2 Application without search report 
No.:EP2566859
Date:13.03.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 10.11.2011 takes the place of the publication of the European patent application.
[2013/11]
Type: B1 Patent specification 
No.:EP2566859
Date:21.12.2016
Language:EN
[2016/51]
Search report(s)International search report - published on:KR18.05.2012
(Supplementary) European search report - dispatched on:EP01.07.2014
ClassificationIPC:C07D401/04, C07D401/14, C07D413/14, A61K31/444, A61K31/496, A61P3/10, A61P3/06, C07D213/81, C07D239/557
[2014/31]
CPC:
C07D401/04 (EP,KR,US); A61K31/4545 (KR); A61K47/02 (EP);
A61K47/26 (EP); A61K9/0019 (EP); A61K9/2009 (EP);
A61K9/2013 (EP); A61K9/2018 (EP); A61K9/2027 (EP);
A61K9/2059 (EP); A61K9/4858 (EP); A61K9/4866 (EP);
A61P1/18 (EP); A61P13/12 (EP); A61P17/06 (EP);
A61P19/10 (EP); A61P25/00 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P27/06 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/08 (EP); A61P3/10 (EP); A61P31/06 (EP);
A61P31/08 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P43/00 (EP); A61P5/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D213/81 (EP,US);
C07D239/557 (EP,US); C07D401/06 (EP,US); C07D401/12 (EP,US);
C07D401/14 (EP,KR,US); C07D403/04 (EP,US); C07D403/14 (EP,US);
C07D405/12 (EP,US); C07D405/14 (EP,US) (-)
Former IPC [2013/11]C07D401/04, C07D401/14, C07D413/14, A61K31/444, A61K31/496, A61P3/10, A61P3/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/11]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PICOLINAMID- UND PYRIMIDIN-4-CARBOXAMID-VERBINDUNGEN, VERFAHREN ZU IHRER HERSTELLUNG UND PHARMAZEUTISCHE ZUSAMMENSETZUNG DAMIT[2013/11]
English:PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME[2013/11]
French:COMPOSÉS DE PICOLINAMIDE ET DE PYRIMIDINE-4-CARBOXAMIDE, LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITION PHARMACEUTIQUE LES COMPRENANT[2013/11]
Entry into regional phase07.11.2012National basic fee paid 
07.11.2012Search fee paid 
07.11.2012Designation fee(s) paid 
07.11.2012Examination fee paid 
Examination procedure07.11.2012Examination requested  [2013/11]
16.01.2015Amendment by applicant (claims and/or description)
02.06.2015Despatch of a communication from the examining division (Time limit: M06)
03.12.2015Reply to a communication from the examining division
04.01.2016Despatch of a communication from the examining division (Time limit: M04)
12.05.2016Reply to a communication from the examining division
07.07.2016Communication of intention to grant the patent
08.11.2016Fee for grant paid
08.11.2016Fee for publishing/printing paid
08.11.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.06.2015
Opposition(s)22.09.2017No opposition filed within time limit [2017/48]
Fees paidRenewal fee
26.03.2013Renewal fee patent year 03
25.04.2014Renewal fee patent year 04
28.05.2015Renewal fee patent year 05
18.05.2016Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.05.2011
AL21.12.2016
AT21.12.2016
BE21.12.2016
CY21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
MK21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
TR21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
MT04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
[2020/33]
Former [2020/15]HU04.05.2011
AT21.12.2016
BE21.12.2016
CY21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
MK21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
TR21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
MT04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
Former [2019/51]HU04.05.2011
AT21.12.2016
BE21.12.2016
CY21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
MK21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
MT04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
Former [2019/46]HU04.05.2011
AT21.12.2016
BE21.12.2016
CY21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
MT04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
Former [2019/31]HU04.05.2011
AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
MT04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
Former [2018/43]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
MT04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
Former [2018/29]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
CH31.05.2017
FR31.05.2017
LI31.05.2017
Former [2018/23]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
IE04.05.2017
LU04.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/21]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
GB04.05.2017
LU04.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/17]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
LU04.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/13]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
CH31.05.2017
LI31.05.2017
LU31.05.2017
Former [2018/06]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
LU31.05.2017
Former [2018/01]AT21.12.2016
BE21.12.2016
CZ21.12.2016
DK21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
LU31.05.2017
Former [2017/41]AT21.12.2016
BE21.12.2016
CZ21.12.2016
EE21.12.2016
ES21.12.2016
FI21.12.2016
HR21.12.2016
IT21.12.2016
LT21.12.2016
LV21.12.2016
NL21.12.2016
PL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
LU31.05.2017
Former [2017/35]CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
NL21.12.2016
RO21.12.2016
RS21.12.2016
SE21.12.2016
NO21.03.2017
GR22.03.2017
Former [2017/31]FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
NL21.12.2016
RS21.12.2016
SE21.12.2016
NO21.03.2017
GR22.03.2017
Former [2017/28]FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
RS21.12.2016
SE21.12.2016
NO21.03.2017
GR22.03.2017
Former [2017/12]LV21.12.2016
Documents cited:Search[A]  - GE ET AL, "11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.", CURRENT MEDICINAL CHEMISTRY, (20100101), vol. 17, no. 5, ISSN 0929-8673, pages 412 - 422, XP055122277 [A] 1-11 * section 2.2; page 415 *

DOI:   http://dx.doi.org/10.2174/092986710790226147
International search[A]US2008032967  (ASHWELL MARK A [US], et al);
 [X]US2009197859  (COLLANTES ELIZABETH MARTHA [US], et al);
 [A]US2010022546  (JIMENENZ HERMOGENES N [US], et al)
ExaminationWO2009147190
    - BONAFOUX D F ET AL, "Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 18, no. 1, ISSN 0968-0896, (20100101), pages 403 - 414, (20091027), XP026810732
by applicantUS2009197859
 US2010022546
    - MASUZAKI H., SCIENCE, (2001), vol. 294, pages 2166 - 2170
    - MASUZAKI H., J. CLIN. INVEST., (2003), vol. 112, pages 83 - 90
    - MORTON N. M., J. BIOL. CHEM., (2001), vol. 276, pages 41293 - 41300
    - GE ET AL., CURRENT MEDICINAL CHEMISTRY, (2010), vol. 17, pages 412 - 422
    - ANDREW, R. C. J., CLIN. ENDOCRIONL. METAB., (2003), vol. 88, pages 285 - 291
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.